C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation

Jiyoun Lee, Ara Koh, Heeyoon Jeong, Eui Kim, Tae-Sun Ha, Moin A Saleem, Sung Ho Ryu

Research output: Contribution to journalArticle (Academic Journal)peer-review

12 Citations (Scopus)


Hypertrophy is a prominent feature of damaged podocytes in diabetic kidney disease (DKD). mTORC1 hyperactivation leads to podocyte hypertrophy, but the detailed mechanism of how mTORC1 activation occurs under pathological conditions is not completely known. Moreover, reduced nephrin tyrosine phosphorylation has been observed in podocytes under pathological conditions, but the molecular mechanism linking nephrin phosphorylation and pathology is unclear so far. In this study, we observed a significant increase in C1-Ten level in diabetic kidney and in high glucose-induced damaged podocytes. C1-Ten acts as a protein tyrosine phosphatase (PTPase) at the nephrin-PI3K binding site and renders PI3K for IRS-1, thereby activating mTORC1. Furthermore, C1-Ten causes podocyte hypertrophy and proteinuria by increasing mTORC1 activity in vitro and in vivo. These findings demonstrate the relationship between nephrin dephosphorylation and the mTORC1 pathway, mediated by C1-Ten PTPase activity. We suggest that C1-Ten contributes to the pathogenesis of DKD by inducing podocyte hypertrophy under high glucose conditions.

Original languageEnglish
Pages (from-to)12346
JournalScientific Reports
Issue number1
Publication statusPublished - 27 Sept 2017


  • Journal Article


Dive into the research topics of 'C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation'. Together they form a unique fingerprint.

Cite this